交易 Caribou Biosciences, Inc. - CRBU CFD
新增到我的最愛- 概括
- 曆史數據
- 活動
- 收入報表
- 資産負債表
- 現金流
- 所有權
交易條件
價差 | 0.05 | ||||||||
多頭倉位隔夜費用
Long position overnight fee
前往平台 | -0.024874% | ||||||||
空頭倉位隔夜費用
Short position overnight fee
前往平台 | 0.002651% | ||||||||
隔夜費時間 | 21:00 (UTC) | ||||||||
最小成交量 | 1 | ||||||||
貨幣 | USD | ||||||||
保證金 | 20% | ||||||||
股票交易 | United States of America | ||||||||
交易委員會 | 0% |
*Information provided by Capital.com
- 上週
- 上個月
- 去年
- 過去兩年
- 最大
- 每日
- 每週
- 每月
日期 | 關閉 | 更改 | 變化 (%) | 打開 | 高 | 低 |
---|---|---|---|---|---|---|
Mar 30, 2023 | 5.11 | -0.04 | -0.78% | 5.15 | 5.25 | 4.90 |
Mar 29, 2023 | 5.13 | 0.34 | 7.10% | 4.79 | 5.18 | 4.67 |
Mar 28, 2023 | 4.69 | 0.03 | 0.64% | 4.66 | 4.87 | 4.54 |
Mar 27, 2023 | 4.68 | 0.06 | 1.30% | 4.62 | 4.78 | 4.49 |
Mar 24, 2023 | 4.62 | 0.38 | 8.96% | 4.24 | 4.69 | 4.18 |
Mar 23, 2023 | 4.26 | -0.11 | -2.52% | 4.37 | 4.43 | 4.10 |
Mar 22, 2023 | 4.32 | -0.43 | -9.05% | 4.75 | 4.75 | 4.31 |
Mar 21, 2023 | 4.79 | -0.08 | -1.64% | 4.87 | 4.90 | 4.74 |
Mar 20, 2023 | 4.85 | -0.04 | -0.82% | 4.89 | 4.91 | 4.69 |
Mar 17, 2023 | 4.91 | -0.02 | -0.41% | 4.93 | 5.02 | 4.80 |
Mar 16, 2023 | 5.02 | -0.07 | -1.38% | 5.09 | 5.15 | 4.91 |
Mar 15, 2023 | 5.15 | 0.10 | 1.98% | 5.05 | 5.25 | 5.02 |
Mar 14, 2023 | 5.18 | -0.25 | -4.60% | 5.43 | 5.51 | 5.10 |
Mar 13, 2023 | 5.30 | 0.25 | 4.95% | 5.05 | 5.34 | 5.02 |
Mar 10, 2023 | 5.14 | -0.29 | -5.34% | 5.43 | 5.48 | 4.93 |
Mar 9, 2023 | 5.48 | -0.35 | -6.00% | 5.83 | 5.85 | 5.33 |
Mar 8, 2023 | 5.85 | 0.02 | 0.34% | 5.83 | 5.92 | 5.75 |
Mar 7, 2023 | 5.86 | 0.03 | 0.51% | 5.83 | 6.04 | 5.70 |
Mar 6, 2023 | 5.77 | -0.32 | -5.25% | 6.09 | 6.09 | 5.54 |
Mar 3, 2023 | 6.09 | 0.17 | 2.87% | 5.92 | 6.11 | 5.86 |
Caribou Biosciences, Inc. Events
时间(协调世界时) (UTC) | 国家 | 事件 |
---|---|---|
No events scheduled |
- 年度
- 每季度
2022 | 2021 | 2020 | 2019 | |
---|---|---|---|---|
總收入 | 13.851 | 9.598 | 12.361 | 5.788 |
收入 | 13.851 | 9.598 | 12.361 | 5.788 |
總營業費用 | 120.25 | 74.993 | 48.485 | 40.093 |
銷售/一般/行政費用,總計 | 38.02 | 24.322 | 14.06 | 16.458 |
研究與開發 | 82.23 | 52.255 | 34.425 | 23.635 |
營業收入 | -106.399 | -65.395 | -36.124 | -34.305 |
利息收入(費用),非經營淨值 | -0.133 | 0.14 | -0.517 | 3.337 |
其他,淨值 | 7.181 | -1.347 | 0.514 | 0 |
稅前淨收入 | -99.351 | -66.602 | -36.127 | -30.968 |
稅後淨收入 | -99.421 | -66.923 | -34.308 | -23.431 |
未計算非常項目前的淨收益 | -99.421 | -66.923 | -34.308 | -23.431 |
淨收入 | -99.421 | -66.923 | -34.308 | -23.431 |
普通股股東可獲收益 (不含非經常性項目) | -99.421 | -66.923 | -34.308 | -23.431 |
普通股股東可獲收益 (含非經常性項目) | -99.421 | -66.923 | -34.308 | -23.431 |
攤薄淨收入 | -99.421 | -66.923 | -34.308 | -23.431 |
攤薄後加權平均股 | 60.8011 | 60.2632 | 56.7092 | 56.7092 |
扣除特別項目的每股攤薄盈利 | -1.63518 | -1.11051 | -0.60498 | -0.41318 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | |
每股正常攤薄盈利 | -1.63518 | -1.1276 | -0.60498 | -0.41318 |
異常費用(收入) | 0 | -1.584 |
Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | |
---|---|---|---|---|---|
總收入 | 3.692 | 3.303 | 4.192 | 2.664 | 2.559 |
收入 | 3.692 | 3.303 | 4.192 | 2.664 | 2.559 |
總營業費用 | 34.27 | 29.84 | 32.623 | 23.517 | 22.964 |
銷售/一般/行政費用,總計 | 8.534 | 9.849 | 10.044 | 9.593 | 7.853 |
研究與開發 | 25.736 | 19.991 | 22.579 | 13.924 | 15.111 |
營業收入 | -30.578 | -26.537 | -28.431 | -20.853 | -20.405 |
利息收入(費用),非經營淨值 | -0.06 | 0.031 | -0.016 | 0.163 | 0.076 |
其他,淨值 | 3.719 | -0.141 | 1.75 | 1.602 | 2.171 |
稅前淨收入 | -26.919 | -26.647 | -26.697 | -19.088 | -18.158 |
稅後淨收入 | -26.989 | -26.647 | -26.697 | -19.088 | -18.479 |
未計算非常項目前的淨收益 | -26.989 | -26.647 | -26.697 | -19.088 | -18.479 |
淨收入 | -26.989 | -26.647 | -26.697 | -19.088 | -18.479 |
普通股股東可獲收益 (不含非經常性項目) | -26.989 | -26.647 | -26.697 | -19.088 | -18.479 |
普通股股東可獲收益 (含非經常性項目) | -26.989 | -26.647 | -26.697 | -19.088 | -18.479 |
攤薄淨收入 | -26.989 | -26.647 | -26.697 | -19.088 | -18.479 |
攤薄後加權平均股 | 61.01 | 60.8869 | 60.7577 | 60.5462 | 60.2632 |
扣除特別項目的每股攤薄盈利 | -0.44237 | -0.43765 | -0.4394 | -0.31526 | -0.30664 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
每股正常攤薄盈利 | -0.44237 | -0.43765 | -0.4394 | -0.31526 | -0.30664 |
異常費用(收入) | 0 | 0 | 0 | 0 |
- 年度
- 每季度
2021 | 2020 | 2019 | |
---|---|---|---|
流動資産總額 | 391.192 | 24.306 | 57.008 |
現金和短期投資 | 375.832 | 15.953 | 49.471 |
現金等價物 | 240.42 | 15.953 | 41.07 |
短期投資 | 135.412 | 0 | 8.401 |
應收賬款總額,淨額 | 8.124 | 5.16 | 3.982 |
Accounts Receivable - Trade, Net | 2.641 | 1.478 | 0.841 |
Prepaid Expenses | 6.565 | 2.433 | 3.182 |
Other Current Assets, Total | 0.671 | 0.76 | 0.373 |
Total Assets | 442.356 | 36.046 | 61.933 |
Property/Plant/Equipment, Total - Net | 4.887 | 3.502 | 4.332 |
Property/Plant/Equipment, Total - Gross | 8.964 | 6.598 | 6.59 |
Accumulated Depreciation, Total | -4.077 | -3.096 | -2.258 |
Long Term Investments | 45.302 | 7.626 | 0 |
Other Long Term Assets, Total | 0.975 | 0.612 | 0.593 |
Total Current Liabilities | 25.829 | 12.389 | 10.078 |
Accounts Payable | 3.99 | 2.601 | 2.537 |
Accrued Expenses | 12.089 | 8.151 | 5.653 |
Notes Payable/Short Term Debt | 0 | 0 | 0 |
Current Port. of LT Debt/Capital Leases | 0 | 0.654 | 0 |
Other Current Liabilities, Total | 9.75 | 0.983 | 1.888 |
Total Liabilities | 54.531 | 18.16 | 13.147 |
Total Long Term Debt | 0 | 0.924 | 0 |
Long Term Debt | 0 | 0.924 | 0 |
Deferred Income Tax | 0.476 | 0.155 | 0.65 |
Other Liabilities, Total | 28.226 | 4.692 | 2.419 |
Total Equity | 387.825 | 17.886 | 48.786 |
Preferred Stock - Non Redeemable, Net | 0 | 41.323 | 41.323 |
Common Stock | 0.006 | 0.001 | 0.001 |
Additional Paid-In Capital | 485.748 | 7.433 | 4.025 |
Retained Earnings (Accumulated Deficit) | -97.794 | -30.871 | 3.437 |
Total Liabilities & Shareholders’ Equity | 442.356 | 36.046 | 61.933 |
Total Common Shares Outstanding | 60.2632 | 56.7092 | 56.7092 |
Other Equity, Total | -0.135 |
Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
---|---|---|---|---|---|
流動資産總額 | 368.01 | 391.192 | 449.047 | 142.967 | 155.925 |
現金和短期投資 | 353.731 | 375.832 | 435.31 | 129.524 | 145.924 |
現金等價物 | 147.63 | 240.42 | 435.31 | 129.524 | 145.924 |
應收賬款總額,淨額 | 6.037 | 8.124 | 7.785 | 8.407 | 5.825 |
Accounts Receivable - Trade, Net | 1.868 | 2.641 | 2.431 | 0.832 | 1.049 |
Prepaid Expenses | 7.276 | 6.565 | 5.189 | 3.759 | 3.096 |
Other Current Assets, Total | 0.966 | 0.671 | 0.763 | 1.277 | 1.08 |
Total Assets | 445.997 | 442.356 | 461.96 | 158.397 | 167.965 |
Property/Plant/Equipment, Total - Net | 31.765 | 4.887 | 4.477 | 4.408 | 3.38 |
Property/Plant/Equipment, Total - Gross | 36.15 | 8.964 | 8.282 | 7.952 | 6.695 |
Accumulated Depreciation, Total | -4.385 | -4.077 | -3.805 | -3.544 | -3.315 |
Long Term Investments | 44.758 | 45.302 | 7.626 | 7.626 | 7.626 |
Other Long Term Assets, Total | 1.464 | 0.975 | 0.81 | 3.396 | 1.034 |
Total Current Liabilities | 26.667 | 25.829 | 26.158 | 26.007 | 22.21 |
Accounts Payable | 1.814 | 3.99 | 3.482 | 4.029 | 3.117 |
Accrued Expenses | 11.215 | 12.089 | 12.288 | 11.034 | 10.929 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Port. of LT Debt/Capital Leases | 0 | 0 | 0 | 0.655 | |
Other Current Liabilities, Total | 13.638 | 9.75 | 10.388 | 10.944 | 7.509 |
Total Liabilities | 74.2 | 54.531 | 57.559 | 55.938 | 53.504 |
Total Long Term Debt | 0 | 0 | 0 | 0 | 0.926 |
Long Term Debt | 0 | 0 | 0 | 0.926 | |
Deferred Income Tax | 0.476 | 0.476 | 0.155 | 0.155 | 0.155 |
Other Liabilities, Total | 47.057 | 28.226 | 31.246 | 29.776 | 30.213 |
Total Equity | 371.797 | 387.825 | 404.401 | 102.459 | 114.461 |
Preferred Stock - Non Redeemable, Net | 0 | 0 | 0 | 150.15 | 150.15 |
Common Stock | 0.006 | 0.006 | 0.006 | 0.001 | 0.001 |
Additional Paid-In Capital | 489.762 | 485.748 | 483.71 | 10.649 | 8.34 |
Retained Earnings (Accumulated Deficit) | -116.882 | -97.794 | -79.315 | -58.341 | -44.03 |
Total Liabilities & Shareholders’ Equity | 445.997 | 442.356 | 461.96 | 158.397 | 167.965 |
Total Common Shares Outstanding | 60.6896 | 60.2632 | 60.0213 | 59.9708 | 56.7092 |
短期投資 | 206.101 | 135.412 | |||
Other Equity, Total | -1.089 | -0.135 |
- 年度
- 每季度
2021 | 2020 | 2019 | |
---|---|---|---|
淨收入/起跑線 | -66.923 | -34.308 | -23.431 |
經營活動産生的現金 | -32.519 | -33.215 | -32.006 |
經營活動産生的現金 | 0.984 | 0.9 | 0.751 |
非現金物品 | 4.353 | 0.016 | -1.059 |
Cash Taxes Paid | 0.011 | 0.021 | 1.809 |
營運資金的變化 | 29.067 | 0.177 | -8.267 |
投資活動産生的現金 | -176.397 | 6.363 | 27.233 |
資本支出 | -2.121 | -0.317 | -0.884 |
其他投資現金流量項目,總計 | -174.276 | 6.68 | 28.117 |
融資活動産生的現金 | 433.429 | 1.735 | 0.172 |
股票的發行(報廢),淨額 | 432.398 | 1.848 | 0.217 |
債務的發行(退還),淨額 | 1.031 | -0.113 | -0.045 |
現金淨變化 | 224.513 | -25.117 | -4.601 |
Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
---|---|---|---|---|---|
Net income/Starting Line | -19.088 | -66.923 | -48.444 | -27.47 | -13.159 |
Cash From Operating Activities | -21.673 | -32.519 | -11.13 | 3.837 | 20.313 |
Cash From Operating Activities | 0.308 | 0.984 | 0.711 | 0.451 | 0.221 |
Non-Cash Items | 2.215 | 4.353 | 4.88 | 1.542 | 1.036 |
Cash Taxes Paid | 0 | 0.011 | 0.011 | 0.011 | 0 |
Cash Interest Paid | 0 | 0.001 | |||
Changes in Working Capital | -5.108 | 29.067 | 31.723 | 29.314 | 32.215 |
Cash From Investing Activities | -72.107 | -176.397 | -2.436 | -0.506 | -0.022 |
Capital Expenditures | -0.723 | -2.121 | -1.436 | -0.506 | -0.022 |
Other Investing Cash Flow Items, Total | -71.384 | -174.276 | -1 | 0 | 0 |
Cash From Financing Activities | 0.99 | 433.429 | 432.969 | 110.286 | 109.68 |
Issuance (Retirement) of Stock, Net | 0.99 | 432.398 | 431.938 | 109.957 | 109.799 |
Issuance (Retirement) of Debt, Net | 0 | 1.031 | 1.031 | 1.031 | -0.119 |
Net Change in Cash | -92.79 | 224.513 | 419.403 | 113.617 | 129.971 |
Financing Cash Flow Items | -0.702 |
投資者名稱 | 投資者類型 | 流通股百分比 | 持有股份 | 股份變動 | 持有日期 | 換手率 |
---|---|---|---|---|---|---|
PFM Health Sciences, LP | Hedge Fund | 7.2754 | 4459783 | -1540217 | 2022-12-31 | MED |
BlackRock Institutional Trust Company, N.A. | Investment Advisor | 6.6832 | 4096777 | 277588 | 2022-12-31 | LOW |
Haurwitz (Rachel E. Ph.D.) | Individual Investor | 5.5129 | 3379395 | 10000 | 2023-03-20 | LOW |
State Street Global Advisors (US) | Investment Advisor/Hedge Fund | 5.2184 | 3198893 | 803423 | 2022-12-31 | LOW |
Avidity Partners Management LP | Hedge Fund | 4.7025 | 2882600 | -290000 | 2022-12-31 | HIGH |
Rokos Capital Management LLP | Hedge Fund | 4.4831 | 2748139 | 840630 | 2022-12-31 | HIGH |
The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 4.1939 | 2570827 | 26789 | 2022-12-31 | LOW |
Pictet Asset Management Ltd. | Investment Advisor/Hedge Fund | 4.1662 | 2553878 | -737020 | 2022-12-31 | LOW |
Elmwood Wealth Management, INC. | Investment Advisor | 3.8569 | 2364240 | 0 | 2022-12-31 | LOW |
EIDP Inc | Corporation | 3.3573 | 2058000 | -1093311 | 2022-05-31 | MED |
BofA Global Research (US) | Research Firm | 3.008 | 1843902 | 1668395 | 2022-12-31 | LOW |
Fidelity Management & Research Company LLC | Investment Advisor | 2.3541 | 1443046 | -547 | 2022-12-31 | LOW |
Morgan Stanley & Co. LLC | Research Firm | 1.982 | 1214933 | 30615 | 2022-12-31 | MED |
Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 1.6819 | 1030987 | 45617 | 2022-12-31 | LOW |
Alkeon Capital Management LLC | Investment Advisor/Hedge Fund | 1.4575 | 893424 | -138016 | 2022-12-31 | LOW |
Fidelity International | Investment Advisor | 1.404 | 860666 | 0 | 2022-12-31 | LOW |
Assenagon Asset Management S.A. | Investment Advisor | 1.3944 | 854738 | 55247 | 2022-12-31 | HIGH |
Maverick Capital, Ltd. | Hedge Fund | 1.0645 | 652542 | 0 | 2022-12-31 | MED |
Tekla Capital Management LLC | Investment Advisor | 0.9252 | 567147 | 0 | 2022-12-31 | LOW |
JPMorgan Asset Management U.K. Limited | Investment Advisor/Hedge Fund | 0.9215 | 564855 | -1059 | 2022-12-31 | LOW |
差價合約交易計算器
如果您在特定日期(選取一個日期)開立差價合約交易並在不同日期(選取一個日期)關閉交易,計算您的假設盈虧。
交易佣金
0
- 1:1
槓桿
1:1
- 20
- 100
- 500
- 1000
- 10000
投資
交易規模(槓桿 x 投資):
打開
關閉
做空 做多
Industry: | Biotechnology & Medical Research (NEC) |
2929 7Th Street, Ste 120
BERKELEY
CALIFORNIA 94710
US
收入報表
- Annual
- Quarterly
人們也觀看
還在尋找值得信賴的經紀商?
加入全球 500.000 多名交易者,選擇與 Capital.com 交易